PDT Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
PDT Partners's AMGN Position: Q2 2025 in Review
PDT Partners sold out of Amgen (AMGN) in Q2 2025, closing a stake of 3,689 shares — an estimated $1.15M sold.
PDT Partners first reported a position in AMGN in Q2 2013 and held it in 23 quarters. The position peaked at $50.4M in Q3 2015. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- PDT Partners reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- PDT Partners sold 3,689 Amgen shares in Q2 2025, an estimated $1.15M.
- PDT Partners first reported a position in Amgen in Q2 2013 and held it in 23 quarters.
- PDT Partners's Amgen position peaked at $50.4M in Q3 2015.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.